Tingting Luo

Guangdong Provincial Key Laboratory Of Digestive Cancer Research
Shenzhen, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

MBD2 suppresses SFRP1 expression and promotes colorectal cancer development by blocking MED19 binding to its methylated promoter.

MBD2 suppresses SFRP1 expression and promotes colorectal cancer development by blocking MED19 binding to its methylated promoter.

Journal: Cancer biology & therapy

Published: May 05, 2026

Gold Nanoplatforms for Phenotypic Reprogramming and Closed-Loop Theranostics of Cancer Stem Cells.

Gold Nanoplatforms for Phenotypic Reprogramming and Closed-Loop Theranostics of Cancer Stem Cells.

Journal: International journal of nanomedicine

Published: March 03, 2026

Immunometabolic regulation in gouty arthritis: current evidence, mechanistic insights, and remaining challenges.

Immunometabolic regulation in gouty arthritis: current evidence, mechanistic insights, and remaining challenges.

Journal: Frontiers in immunology

Published: January 24, 2026

Development of an in situ small intestinal injection technique for targeted macromolecule delivery and in vivo functional studies in mice.

Development of an in situ small intestinal injection technique for targeted macromolecule delivery and in vivo functional studies in mice.

Journal: Animal models and experimental medicine

Published: May 06, 2025

Orphan Class A GPCRs Signature Predicts Prognosis and Immune Microenvironment in Gastric Cancer: GPR176 Drives Tumor Progression Through Wnt Signaling and Macrophage Polarization.

Orphan Class A GPCRs Signature Predicts Prognosis and Immune Microenvironment in Gastric Cancer: GPR176 Drives Tumor Progression Through Wnt Signaling and Macrophage Polarization.

Journal: Mediators of inflammation

Published: April 07, 2025

Comprehensive Bioinformatics Analyses and Experimental Validation of the Cell Cycle Related Protein SAPCD2 as a New Biomarker and Potential Therapeutic Target in Pancreatic Cancer.

Comprehensive Bioinformatics Analyses and Experimental Validation of the Cell Cycle Related Protein SAPCD2 as a New Biomarker and Potential Therapeutic Target in Pancreatic Cancer.

Journal: Journal of inflammation research

Published: October 22, 2024

BiTiS3 bio-transducer with explosive on-demand generation of NO gas for synergetic cancer therapy.

BiTiS3 bio-transducer with explosive on-demand generation of NO gas for synergetic cancer therapy.

Journal: Biosensors & bioelectronics

Published: September 21, 2023

Transformation of Black Phosphorus through Lattice Reconstruction for NIR-II-Responsive Cancer Therapy.

Transformation of Black Phosphorus through Lattice Reconstruction for NIR-II-Responsive Cancer Therapy.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: August 16, 2023

Exploring the translational potential of PLGA nanoparticles for intra-articular rapamycin delivery in osteoarthritis therapy.

Exploring the translational potential of PLGA nanoparticles for intra-articular rapamycin delivery in osteoarthritis therapy.

Journal: Journal of nanobiotechnology

Published: August 01, 2023

NIR-II Responsive Nanohybrids Incorporating Thermosensitive Hydrogel as Sprayable Dressing for Multidrug-Resistant-Bacteria Infected Wound Management.

NIR-II Responsive Nanohybrids Incorporating Thermosensitive Hydrogel as Sprayable Dressing for Multidrug-Resistant-Bacteria Infected Wound Management.

Journal: ACS nano

Published: June 14, 2023

Applying Rituximab During the Conditioning Regimen Prevents Epstein-Barr Virus Infection Following Allogeneic Hematopoietic Stem Cell Transplant in a Children's Cohort: A Retrospective Case-Control Study.

Applying Rituximab During the Conditioning Regimen Prevents Epstein-Barr Virus Infection Following Allogeneic Hematopoietic Stem Cell Transplant in a Children's Cohort: A Retrospective Case-Control Study.

Journal: Infectious diseases and therapy

Published: May 04, 2023

Biodegradable FePS3 nanoplatform for efficient treatment of osteosarcoma by combination of gene and NIR-II photothermal therapy.

Biodegradable FePS3 nanoplatform for efficient treatment of osteosarcoma by combination of gene and NIR-II photothermal therapy.

Journal: Journal of nanobiotechnology

Published: February 23, 2023

Showing 1-12 of 25

Last Updated: 09/26/2026